4d Molecular Therapeutics In shares owned by Geode Capital Management
Quarter-by-quarter ownership of 4d Molecular Therapeutics In (FDMT) shares owned by Geode Capital Management
from 13F filings
Historical chart of Geode Capital Management investment in 4d Molecular Therapeutics In
Tip: Access up to 7 years of quarterly data
All positions including 4d Molecular Therapeutics In held by Geode Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in 4d Molecular Therapeutics In by Geode Capital Management
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2024-06-30 | $22M | 1.1M | 20.99 |
2024-03-31 | $28M | 873k | 31.86 |
2023-09-30 | $9.4M | 742k | 12.73 |
2023-06-30 | $13M | 690k | 18.07 |
2023-03-31 | $9.9M | 578k | 17.19 |
2022-12-31 | $13M | 562k | 22.21 |
2022-09-30 | $4.3M | 529k | 8.04 |
2022-06-30 | $3.4M | 493k | 6.98 |
2022-03-31 | $7.2M | 479k | 15.12 |
2021-12-31 | $11M | 482k | 21.94 |
2021-09-30 | $9.2M | 342k | 26.97 |
2021-06-30 | $4.0M | 167k | 24.08 |
2021-03-31 | $6.3M | 146k | 43.38 |
2020-12-31 | $529k | 13k | 41.39 |